A Study of Ixekizumab in Participants With Plaque Psoriasis

NCT02993471 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Drug Cocktail
DRUG: Ixekizumab

Sponsor

Eli Lilly and Company